Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

about

Repurposing anticancer drugs for targeting necroptosis.Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors.The role of necroptosis in the treatment of diseases.

P2860

Q49717299-333C83B2-19F2-4952-94B0-E458A1C419A8 Q54119475-BC206097-D6E3-4DC7-B837-A2C94AAD31F7 Q55386853-EAC2FE4F-29DC-4F1D-B02F-6026D7845451

P2860

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

Item

http://www.wikidata.org/entity/Q42366610

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@en

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@nl

type

Item

label

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@en

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@nl

prefLabel

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@en

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@nl

P1476

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

@en

P2093

Barbara Schenk

http://www.w3.org/2001/XMLSchema#string

Peter Vandenabeele

http://www.w3.org/2001/XMLSchema#string

Sofie Martens

http://www.w3.org/2001/XMLSchema#string

P2860

Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase

Structural basis of RIP1 inhibition by necrostatins

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

The mechanism of necroptosis in normal and cancer cells

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor

P304

68208-68220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19919

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Fulda

Friederike Feldmann

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978109

http://www.w3.org/2001/XMLSchema#string

P921

necroptosis

P932

5620249

http://www.w3.org/2001/XMLSchema#string

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

about

P2860

P2860

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932